ClinicalTrials.gg
Not yet recruitingNCT07017530CHEMO-CogExUpdated Jun 12, 2025

Cognitive Training and Exercise for Women With Breast Cancer and Cognitive Impairment

An interventional study of Cognitive training and Psychoeducational therapy in Breast Cancer, sponsored by Universidad de Extremadura. Not yet recruiting at 1 site in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-12.

Sponsored by Universidad de Extremadura · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Chemotherapy-related cognitive impairment is a prevalent and distressing condition among breast cancer survivors, adversely affecting memory, attention, and overall cognitive function, thereby diminishing quality of life. Emerging evidence suggests that multimodal interventions combining cognitive training and adapted physical exercise may mitigate these cognitive deficits and associated symptoms. This study aims to evaluate the efficacy of a 12-week structured intervention integrating cognitive training and supervised physical exercise in improving cognitive function, fatigue, sleep quality, psychological distress, and overall well-being in women with breast cancer. Furthermore, it seeks to determine the optimal timing for such interventions to maximize their effectiveness. A randomized controlled trial involving 220 participants will assess subjective and objective cognitive outcomes, brain activity, and physical performance. The findings from this research may contribute to the development of evidence-based rehabilitation strategies, enhancing cognitive health and quality of life in breast cancer patients.

02

Conditions studied

  • Breast Cancer

Keywords

  • Breast cancer
  • Chemotherapy-Related Cognitive Impairment
  • Cognitive Training
  • Exercise
  • Oncology Nursing
03

In context

Breast Neoplasms

14,825 studies on the registry are indexed under Breast Neoplasms; 3,319 are open to participants now.

This study's planned enrollment of 220 is above the median of 72 across 10,896 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Universidad de Extremadura is the lead sponsor of 39 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18 years or older who were diagnosed with stage 0 to IV breast cancer.
  • Women undergoing chemotherapy (at least two cycles) or having completed it at least six months earlier.
  • Cognitive impairment must be reported, with scores below 54 on the FACT-Cog scale

Exclusion criteria

Exclusion Criteria:

  • Women with significant neurological conditions.
  • Women with psychiatric conditions.
  • Women with for physical exercise.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
220 participants (estimated)

Study arms

  • Experimental
    Cognitive training + exercise group during chemotherapy

    Al list two cycles of chemotherapy.

    Other: Cognitive training

  • Experimental
    Cognitive training + exercise group after chemotherapy

    Al list six months after the completion of chemotherapy.

    Other: Cognitive training

  • Active comparator
    Psychoeducational therapy during chemotherapy

    Al list two cycles of chemotherapy.

    Other: Psychoeducational therapy

  • Active comparator
    Psychoeducational therapy after chemotherapy

    Al list six months after the completion of chemotherapy.

    Other: Psychoeducational therapy

Interventions

  • OtherCognitive training

    Combined Intervention of Cognitive Training and Supervised Physical Exercise

    Also known as: Adapted physical activity

  • OtherPsychoeducational therapy

    According to standard clinical practice

06

What researchers measure

Primary outcomes

  1. Subjetive Cognitive function

    It will be assessed using subjective cognitive function measured by Functional Assessment of Cancer Therapy-Cognition (FACT-Cog) scale.

    Time frame: - Baseline - 12 weeks for intervention group - 16 weeks for control group

  2. Objective Cognitive Function

    It will be assessed with Near Infrared Spectroscopy (regional cerebral oxygen saturation).

    Time frame: - Baseline - 12 weeks for intervention group - 16 weeks for control group

Secondary outcomes

  1. Fatigue

    It will be measured with the Fatigue Symptom Inventory (FSI), which assesses the frequency, severity, and perceived interference of fatigue in daily life over the past week

    Time frame: - Baseline - 12 weeks for intervention group - 16 weeks for control group

  2. Sleep quality

    It will be assessed using the Pittsburgh Sleep Quality Index (PSQI), a well-validated questionnaire that evaluates sleep across seven components, including latency, duration, efficiency, disturbances, and the use of sleep medications

    Time frame: - Baseline - 12 weeks for intervention group - 16 weeks for control group

  3. Insomnia

    It will be assessed using the Insomnia Severity Index (ISI). This validated questionnaire consists of seven items that evaluate difficulties with sleep onset, sleep maintenance, and early morning awakening, as well as satisfaction with sleep patterns, interference with daily functioning, perceived impairment, and distress caused by sleep problems

    Time frame: - Baseline - 12 weeks for intervention group - 16 weeks for control group

  4. Psychological distress

    Psychological distress will be assessed using the Hospital Anxiety and Depression Scale (HADS). The HADS consists of 14 items, each scored from 0 to 3, yielding subscale scores for anxiety (HADS-A) and depression (HADS-D) that each range from 0 to 21, with higher scores indicating greater psychological distress (worse outcome). The total score ranges from 0 to 42.

    Time frame: - Baseline - 12 weeks for intervention group - 16 weeks for control group

  5. Quality of life (QoL)

    It will be measured using the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30)

    Time frame: - Baseline - 12 weeks for intervention group - 16 weeks for control group

  6. Abdominal flexor endurance

    It will be assessed using the McQuade Test (seconds)

    Time frame: - Baseline - 12 weeks for intervention group

  7. Upper body and back muscular strength

    It will be assessed using trunk dynamometry (kg)

    Time frame: - Baseline - 12 weeks for intervention group

  8. Lower body endurance

    It will be assessed using the 30-second sit-to-stand test (number of repetitions). The outcome is the number of repetitions completed, with a higher score indicating better lower limb strength and endurance.

    Time frame: - Baseline - 12 weeks for intervention group

  9. Perceived physical fitness

    It will be assessed using the International Fitness Scale (IFIS). It comprises 5 items that evaluate overall fitness, cardiorespiratory fitness, muscular strength, speed-agility, and flexibility. Each item is rated on a 5-point Likert scale ranging from 1 (very poor) to 5 (very good). Higher scores indicate better perceived physical fitness.

    Time frame: - Baseline - 12 weeks for intervention group

  10. Functional exercise capacity

    It will be assessed using the Six-Minute Walk Test (6MWT) (metres)

    Time frame: - Baseline - 12 weeks for intervention group

  11. Perceived effort

    It will be assessed using the Borg Scale of Perceived Exertion.

    Time frame: - 12 weeks for intervention group

07

Study locations

1 site
  • Facultad de Medicina y Ciencias de la Salud
    Badajoz, 06006, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07017530
Lead sponsor
Universidad de Extremadura
Responsible party
Noelia Durán (Principal Investigator, Universidad de Extremadura) — Principal investigator
First posted
Jun 12, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Sep 2026 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Jun 12, 2025

Study contacts

Noelia Durán-Gómez, PhD
Contact
nduran@unex.es
+34924289466

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion